{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:35:37Z","timestamp":1792802137936,"version":"4.5.0"},"reference-count":22,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2024,9,1]]},"abstract":"<jats:sec><jats:title>Importance<\/jats:title><jats:p>Unilateral magnetic resonance\u2013guided focused ultrasound ablation of ventralis intermedius nucleus of the thalamus for essential tremor reduces tremor on 1 side, but untreated contralateral or midline symptoms remain limiting for some patients. Historically, bilateral lesioning produced unacceptable risks and was supplanted by deep brain stimulation; increasing acceptance of unilateral focused ultrasound lesioning has led to interest in a bilateral option.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate the safety and efficacy of staged, bilateral focused ultrasound thalamotomy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This prospective, open-label, multicenter trial treated patients with essential tremor from July 2020 to October 2021, with a 12-month follow-up, at 7 US academic medical centers. Of 62 enrolled patients who had undergone unilateral focused ultrasound thalamotomy at least 9 months prior to enrollment, 11 were excluded and 51 were treated. Eligibility criteria included patient age (22 years and older), medication refractory, tremor severity (Clinical Rating Scale for Tremor [CRST] part A score \u22652 for postural or kinetic tremor), and functional disability (CRST part C score \u22652 in any category).<\/jats:p><\/jats:sec><jats:sec><jats:title>Intervention<\/jats:title><jats:p>A focused ultrasound system interfaced with magnetic resonance imaging allowed real-time alignment of thermography maps with anatomy. Subthreshold sonications allowed target interrogation for efficacy and off-target effects before creating an ablation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Tremor\/motor score (CRST parts A and B) at 3 months for the treated side after treatment was the primary outcome measure, and secondary assessments for efficacy and safety continued to 12 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean (SD) population age was 73 (13.9) years, and 44 participants (86.3%) were male. The mean (SD) tremor\/motor score improved from 17.4 (5.4; 95% CI, 15.9-18.9) to 6.4 (5.3; 95% CI, 4.9 to 7.9) at 3 months (66% improvement in CRST parts A and B scores; 95% CI, 59.8-72.2; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001). There was significant improvement in mean (SD) postural tremor (from 2.5 [0.8]; 95% CI, 2.3 to 2.7 to 0.6 [0.9]; 95% CI, 0.3 to 0.8; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001) and mean (SD) disability score (from 10.3 [4.7]; 95% CI, 9.0-11.6 to 2.2 [2.8]; 95% CI, 1.4-2.9; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001). Twelve participants developed mild (study-defined) ataxia, which persisted in 6 participants at 12 months. Adverse events (159 of 188 [85%] mild, 25 of 188 [13%] moderate, and 1 severe urinary tract infection) reported most commonly included numbness\/tingling (n\u2009=\u200917 total; n\u2009=\u20098 at 12 months), dysarthria (n\u2009=\u200915 total; n\u2009=\u20097 at 12 months), ataxia (n\u2009=\u200912 total; n\u2009=\u20096 at 12 months), unsteadiness\/imbalance (n\u2009=\u200910 total; n\u2009=\u20090 at 12 months), and taste disturbance (n\u2009=\u20097 total; n\u2009=\u20093 at 12 months). Speech difficulty, including phonation, articulation, and dysphagia, were generally mild (rated as not clinically significant, no participants with worsening in all 3 measures) and transient.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Relevance<\/jats:title><jats:p>Staged, bilateral focused ultrasound thalamotomy significantly reduced tremor severity and functional disability scores. Adverse events for speech, swallowing, and ataxia were mostly mild and transient.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial Registration<\/jats:title><jats:p>ClinicalTrials.gov Identifier <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/practicalneurology.com\/news\/fda-allows-study-of-bilateral-ultrasound-treatment-of-essential-tremor\">NCT04112381<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaneurol.2024.2295","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T15:51:15Z","timestamp":1722268275000},"page":"939","source":"Crossref","is-referenced-by-count":72,"title":["Safety and Efficacy of Staged, Bilateral Focused Ultrasound Thalamotomy in Essential Tremor"],"prefix":"10.1001","volume":"81","author":[{"given":"Michael G.","family":"Kaplitt","sequence":"first","affiliation":[{"name":"Department of Neurological Surgery, Weill Cornell Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhor","family":"Krishna","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of North Carolina, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard M.","family":"Eisenberg","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Maryland, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Jeffrey","family":"Elias","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Virginia, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pejman","family":"Ghanouni","sequence":"additional","affiliation":[{"name":"Department of Radiology, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon H.","family":"Baltuch","sequence":"additional","affiliation":[{"name":"Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Rezai","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, West Virginia University, Morgantown"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey H.","family":"Halpern","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Dalm","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul S.","family":"Fishman","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Maryland, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek P.","family":"Buch","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayan","family":"Moosa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Virginia, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harini","family":"Sarva","sequence":"additional","affiliation":[{"name":"Department of Neurology, Cornell University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann Marie","family":"Murray","sequence":"additional","affiliation":[{"name":"Department of Neurology, West Virginia University, Morgantown"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"noi240043r1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.5334\/tohm.632","article-title":"How common is essential tremor? update on the worldwide prevalence of essential tremor.","volume":"11","author":"Louis","year":"2021","journal-title":"Tremor Other Hyperkinet Mov (NY)"},{"issue":"7","key":"noi240043r2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1056\/NEJM200002173420703","article-title":"A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor.","volume":"342","author":"Schuurman","year":"2000","journal-title":"N Engl J Med"},{"issue":"2","key":"noi240043r3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0090-3019(97)00459-X","article-title":"Deep brain stimulation is preferable to thalamotomy for tremor suppression.","volume":"49","author":"Tasker","year":"1998","journal-title":"Surg Neurol"},{"issue":"8","key":"noi240043r4","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1056\/NEJMoa1600159","article-title":"A randomized trial of focused ultrasound thalamotomy for essential tremor.","volume":"375","author":"Elias","year":"2016","journal-title":"N Engl J Med"},{"key":"noi240043r5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.parkreldis.2017.03.017","article-title":"Thalamic DBS with a constant-current device in essential tremor: a controlled clinical trial.","volume":"40","author":"Wharen","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"noi240043r6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/mds.27401","article-title":"Neurological adverse event profile of magnetic resonance imaging-guided focused ultrasound thalamotomy for essential tremor.","volume":"33","author":"Fishman","year":"2018","journal-title":"Mov Disord"},{"issue":"1","key":"noi240043r7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000518662","article-title":"Bilateral magnetic resonance imaging-guided focused ultrasound thalamotomy for essential tremor.","volume":"100","author":"Fukutome","year":"2022","journal-title":"Stereotact Funct Neurosurg"},{"issue":"11","key":"noi240043r8","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1002\/mds.28716","article-title":"Bilateral focused ultrasound thalamotomy for essential tremor (BEST-FUS phase 2 trial).","volume":"36","author":"Iorio-Morin","year":"2021","journal-title":"Mov Disord"},{"issue":"9","key":"noi240043r9","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1136\/jnnp-2020-325278","article-title":"Bilateral staged magnetic resonance-guided focused ultrasound thalamotomy for the treatment of essential tremor: a case series study.","volume":"92","author":"Mart\u00ednez-Fern\u00e1ndez","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"noi240043r10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/mds.26924","article-title":"Speech and language adverse effects after thalamotomy and deep brain stimulation in patients with movement disorders: a meta-analysis.","volume":"32","author":"Alomar","year":"2017","journal-title":"Mov Disord"},{"issue":"2","key":"noi240043r11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3171\/2017.4.JNS162803","article-title":"Clinical improvement associated with targeted interruption of the cerebellothalamic tract following MR-guided focused ultrasound for essential tremor.","volume":"129","author":"Chazen","year":"2018","journal-title":"J Neurosurg"},{"issue":"1","key":"noi240043r12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/neuros\/nyy020","article-title":"Prospective tractography-based targeting for improved safety of focused ultrasound thalamotomy.","volume":"84","author":"Krishna","year":"2019","journal-title":"Neurosurgery"},{"issue":"6","key":"noi240043r13","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/mds.21412","article-title":"Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor.","volume":"22","author":"Stacy","year":"2007","journal-title":"Mov Disord"},{"issue":"1","key":"noi240043r14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00455-011-9336-2","article-title":"The Dysphagia Handicap Index: development and validation.","volume":"27","author":"Silbergleit","year":"2012","journal-title":"Dysphagia"},{"issue":"4","key":"noi240043r15","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"noi240043r16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale.","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"issue":"4","key":"noi240043r17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/14737175.2020.1737017","article-title":"Deep brain stimulation in essential tremor: targets, technology, and a comprehensive review of clinical outcomes.","volume":"20","author":"Wong","year":"2020","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"noi240043r18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1042-3680(18)30477-7","article-title":"Thalamotomy for movement disorders.","volume":"6","author":"Burchiel","year":"1995","journal-title":"Neurosurg Clin N Am"},{"issue":"2","key":"noi240043r19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/neuros\/nyz417","article-title":"Predictors of outcomes after focused ultrasound thalamotomy.","volume":"87","author":"Krishna","year":"2020","journal-title":"Neurosurgery"},{"key":"noi240043r20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5334\/tohm.757","article-title":"Effect of ventral intermediate nucleus deep brain stimulation on vocal tremor in essential tremor.","volume":"13","author":"Ruckart","year":"2023","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"8","key":"noi240043r21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1056\/NEJMoa2202721","article-title":"Trial of globus pallidus focused ultrasound ablation in Parkinson\u2019s disease.","volume":"388","author":"Krishna","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"noi240043r22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/jnnp-2014-307642","article-title":"Unilateral magnetic resonance guided focused ultrasound thalamotomy for essential tremor: practices and clinicoradiological outcomes.","volume":"86","author":"Chang","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2821255\/jamaneurology_kaplitt_2024_oi_240043_1725483561.96553.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T15:06:58Z","timestamp":1725894418000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2821255"}},"subtitle":["An Open-Label Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2024.2295","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,1]]}}}